Summit Therapeutics Inc. - Cash Flow Statement (TTM)

Summit Therapeutics Inc.
MX ˙ BMV ˙ US86627T1088
Cash Flow Statement (TTM)

Summit Therapeutics Inc. Cash Flow Statement shows changes in cash positions over time. Cash Flow Statement data includes Cash from Operating Activities (CFOP), Cash from Investing Activities, and Cash from Financing Activities.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash From Operating Activities -49 -48 -64 -64 -71 -73 -71 -71 -56 -42 -36 -46 -52 -77 -94 -97 -113 -142 -173 -207
Change (%) -1.66 32.65 1.01 10.73 1.69 -2.30 0.06 -21.15 -25.68 -14.12 28.16 13.86 47.30 22.15 3.98 15.80 25.88 21.84 19.49
% of Cash Flow 234.38 -1,868.39 -135.07 -96.25 -121.03 -1,350.71 286.61 154.09 -134.10 -7.21 551.03 300.73 53.08 13.30 1,001.96 729.62 -160.57 -420.91 -115.25 -76.78
Cash From Investing Activities -0 -0 -0 -0 -0 -0 -1 -1 -1 -1 -645 -645 -648 -588 77 -123 -228 -205 -65 286
Change (%) 9.35 -36.82 6.77 -16.90 29.66 105.23 22.61 -2.08 -17.24 103,317.63 -0.08 0.54 -9.34 -113.13 -259.57 85.38 -10.04 -68.30 -538.98
% of Cash Flow 1.84 -16.35 -0.56 -0.42 -0.40 -5.69 2.54 1.67 -1.81 -0.11 9,957.20 4,236.98 660.36 101.84 -824.54 921.46 -324.66 -608.20 -43.33 106.07
Cash From Financing Activities 30 51 106 127 127 78 47 27 101 620 675 675 600 87 7 207 411 381 388 190
Change (%) 71.33 110.57 18.87 0.53 -38.75 -39.41 -42.54 274.00 511.41 8.86 -0.01 -11.08 -85.59 -92.04 2,908.68 98.42 -7.26 1.89 -50.97
% of Cash Flow -141.35 1,963.15 225.28 188.91 215.68 1,449.87 -190.78 -58.90 243.14 107.53 -10,417.67 -4,435.83 -611.46 -14.99 -73.58 -1,550.50 584.72 1,129.16 258.54 70.68
Cash Flow -21 3 47 67 59 5 -25 -46 42 577 -6 -15 -98 -577 -9 -13 70 34 150 269
Change (%) -112.34 1,734.99 41.75 -11.94 -90.89 -560.44 86.11 -190.60 1,282.49 -101.12 134.82 545.11 487.89 -98.38 42.79 -626.16 -51.98 344.98 79.35
% of Cash Flow 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00

Source: Capital IQ

Other Listings
US:SMMT $25.98
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista